Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -3.76Operating Cash Flow per Share
VS
Market
Sector
Industry
History
$ 0.68Close
$ 0.58 - $ 3.8 52-Week Range
Ticker Information
Ticker
GTBPCompany Name
GT BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQGT BIOPHARMA INC - Operating Cash Flow per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
GTBP - OCFPS Historical data
| Date | Net Cash Flow - Operations | Operating Cash Flow per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -10.42M | $ -3.76 | 1 | 2.77M |
| 3/31/2025 | $ -10.94M | $ -4.67 | 1 | 2.35M |
| 12/31/2024 | $ -12.9M | $ -6.8 | 1 | 1.9M |
| 9/30/2024 | $ -12.48M | $ -5.59 | 1 | 2.23M |
| 6/30/2024 | $ -11.71M | $ -6.84 | 1 | 1.71M |
| 3/31/2024 | $ -10.11M | $ -7.32 | 1 | 1.38M |
| 12/31/2023 | $ -8.85M | $ -6.57 | 1 | 1.35M |
| 9/30/2023 | $ -11.1M | $ -8.12 | 1 | 1.37M |
| 6/30/2023 | $ -12.06M | $ -9 | 1 | 1.34M |
| 3/31/2023 | $ -12.91M | $ -9.91 | 1 | 1.3M |
Key Performance Insights, Last 5 Years
- GT BIOPHARMA INC's latest trailing twelve months (TTM) OCFPS stands at $ -38.68.
- Over the past 5 years, GT BIOPHARMA INC's average OCFPS has been $ -13.81.
- The median OCFPS for GT BIOPHARMA INC during this period was $ -10.15
- GT BIOPHARMA INC reached its highest OCFPS over the past 5 years at $ -3.76.
- The lowest OCFPS recorded by GT BIOPHARMA INC in the same timeframe $ -49.68
Similar metrics to Shares WA:
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of Operating Cash Flow per Share
[Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].CF - Operations / (Shares WA * Share Factor)
(=) OCFPS OCFPS for GT BIOPHARMA INC is calculated as follows: CF - Operations [ $ -5.82M ] / (Shares WA [ 150.45K ] * Share Factor [ 1 ])
(=) OCFPS [ $ -38.68 ] GTBP - Operating Cash Flow per Share, Last 5 years
$ -49.68
Minimum
Dec 31, 2020
$ -3.76
Maximum
Jun 30, 2025
$ -13.81
Average
$ -10.15
Median
OCFPS Benchmark AnalysisMarket
The chart above depicts the distribution of OCFPS for companies in the Total Stock Market. The average OCFPS of the companies is $ 1.66 with a standard deviation of $ 3.42.
The following table provides additional summary stats:
OCFPS in the Market:
| filtered constituents | 3.78K |
|---|---|
| min | $ -9.04 |
| max | $ 11.43 |
| average | $ 1.66 |
| median | $ 0.9 |
| std | $ 3.42 |